Publications
65
Citations
1,825
Est. group size
—
Recurring co-author estimate
Active years
37
Publishing since 1989
Xiao Xu's publications span clinical and health-economics research in respiratory and related diseases, including asthma, chronic obstructive pulmonary disease (COPD), and eosinophilic esophagitis, often using real-world insurance claims data to study treatment patterns, healthcare costs, and outcomes of corticosteroid use. A separate strand of work addresses radiation oncology, particularly radiotherapy for lung cancer and brain metastases. The record reflects a mix of observational cohort studies, cost analyses, and clinical treatment evaluations.
Publication activity has been relatively steady over the past decade, averaging about four papers per year over the last five years with no clear upward or downward shift.
Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026
- Efficacy analysis of brain radiotherapy in EGFR mutation non-small cell lung cancer with brain metastasis: a retrospective study
Discover Oncology · 2025
- Advancements in the investigation of radioactive microspheres for brachytherapy
Frontiers in Bioengineering and Biotechnology · 2025
- A*-Thought: Efficient Reasoning via Bidirectional Compression for Low-Resource Settings
arXiv (Cornell University) · 2025
- Characteristics, treatment patterns, healthcare resource utilization, and costs in patients with eosinophilic esophagitis in the United States: a retrospective analysis of insurance claims data
Therapeutic Advances in Gastroenterology · 2025
- Systemic corticosteroid dose–response effects in asthma: an observational cohort study
ERJ Open Research · 2024
- T790M mutation sensitizes non-small cell lung cancer cells to radiation via suppressing SPOCK1
Biochemistry and Biophysics Reports · 2024
- Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: dose‒response effect and toxicity
Discover Oncology · 2024
- Oral Corticosteroid-Related Healthcare Resource Utilization and Associated Costs in Patients with COPD
Advances in Therapy · 2024
- THE AUTHORS RESPOND
Journal of Managed Care & Specialty Pharmacy · 2024
- A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD
International Journal of COPD · 2023
- A cost comparison of benralizumab, mepolizumab, and dupilumab in patients with severe asthma: A US third-party payer perspective
Journal of Managed Care & Specialty Pharmacy · 2023
- Characteristics, treatment patterns, health care resource utilization and costs in patients with bullous pemphigoid: A retrospective analysis of US health insurance claims data
JAAD International · 2023
- Real World Investigation of Eosinophilic-associated Disease Overlap (REVEAL): Persistent Asthma Healthcare Resource Utilization and Associated Cost Sub-study
2023
- Hypofractionated stereotactic radiotherapy for brain metastases in lung cancer patients: Dose‒response effect and toxicity
Research Square · 2023
- Decreased Regional Spontaneous Brain Activity and Cognitive Dysfunction in Patients with Coronary Heart Disease: a Resting-state Functional MRI Study
Academic Radiology · 2022
- The American Journal of Gastroenterology×3
- Journal of Asthma and Allergy×2
- Current Medical Research and Opinion×2
- International Journal of COPD×2
- Journal of Managed Care & Specialty Pharmacy×2
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 11, 2026.
Claim or correct this profile